Two Philadelphia biotech companies scored approval in 2024 for first-of-their-kind gene therapy treatments for solid cancer ...
If you invested $10,000 in Australia's best-performing stock a year ago would have turned that into a $46,400 bonanza. Here's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback